da Silva FA, Stroka A, Fusco V. PHARMACOLOGICAL ASPECTS OF THE MONOCLONAL ANTIBODY (NIVOLUMAB) USING THE PD-1 PATHWAY IN ANTITUMOR TREATMENT OF HODGKIN’S LYMPHOMA. Infarma [Internet]. 2019 Apr. 1 [cited 2024 Sep. 1];31(1):13-9. Available from: https://revistas.cff.org.br/infarma/article/view/2294